<SEC-DOCUMENT>0000950170-24-140428-index.html : 20241226
<SEC-HEADER>0000950170-24-140428.hdr.sgml : 20241226
<ACCEPTANCE-DATETIME>20241226163004
ACCESSION NUMBER:		0000950170-24-140428
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20241216
FILED AS OF DATE:		20241226
DATE AS OF CHANGE:		20241226

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gaslightwala Abizer
		CENTRAL INDEX KEY:			0002049375
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36288
		FILM NUMBER:		241581370

	MAIL ADDRESS:	
		STREET 1:		AKARI THERAPEUTICS, PLC
		STREET 2:		22 BOSTON WHARF ROAD FL 7
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akari Therapeutics Plc
		CENTRAL INDEX KEY:			0001541157
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				981034922
		STATE OF INCORPORATION:			X0

	BUSINESS ADDRESS:	
		STREET 1:		22 BOSTON WHARF ROAD
		STREET 2:		FL 7
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(646) 350-0702

	MAIL ADDRESS:	
		STREET 1:		22 BOSTON WHARF ROAD
		STREET 2:		FL 7
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsus Therapeutics Plc.
		DATE OF NAME CHANGE:	20130621

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Morria Biopharmaceuticals PLC
		DATE OF NAME CHANGE:	20120201
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>aktx-ex24.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: aktx-ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>